Ophthalmology – Thygeson’s Superficial Punctate Keratitis

What the Disorder Represents

Thygeson’s superficial punctate keratitis (TSPK) is a rare, chronic, recurrent corneal epithelial disorder characterized by multiple:

• Gray-white
• Coarse
• Slightly elevated
• Intraepithelial corneal lesions

The classic disease has:

• Little or no conjunctival injection
• No significant stromal inflammation
• No corneal edema
• No anterior chamber inflammation

It is usually:

Bilateral but frequently asymmetric.

Who Develops It

TSPK can occur at almost any age.

It most often presents in:

• Children
• Young adults
• Middle-aged adults

There is no strong consistent sex predilection.

The condition is:

Uncommon.

Why It Develops

The exact cause remains:

Unknown.

An immune-mediated mechanism is favored because:

• Lesions respond dramatically to corticosteroids
• Topical immunomodulators can suppress recurrences
• Disease follows a relapsing-remitting course

A viral trigger has historically been proposed, but:

No specific infectious agent has been established.

HLA Association

An association with:

HLA-DR3

has been reported.

However, HLA testing has:

No role in routine diagnosis or management.

What Patients Usually Notice

Symptoms vary considerably.

Common complaints include:

• Foreign-body sensation
• Mild to moderate irritation
• Photophobia
• Tearing
• Burning
• Fluctuating or mildly blurred vision

Some patients have surprisingly prominent photophobia despite limited slit-lamp findings.

Others may be:

Almost asymptomatic.

Typical Visual Acuity

Visual acuity is often:

• Normal
• Mildly reduced

More significant blur occurs when lesions involve the:

Central visual axis.

Permanent reduction in vision is unusual.

The Classic Slit-Lamp Appearance

The hallmark is:

Multiple discrete gray-white granular epithelial lesions with normal intervening cornea.

Lesions are typically:

• Small
• Round or oval
• Coarse
• Slightly raised
• Centrally or paracentrally distributed

The intervening corneal epithelium is generally:

Clear and relatively normal.

How the Lesions Stain

Lesions may show:

• Minimal fluorescein staining
• Fine punctate staining
• No staining at all

Prominent epithelial ulceration is:

Not typical.

Where the Lesions Are Located

TSPK predominantly affects the:

Corneal epithelium

with possible involvement of the very superficial subepithelial region.

There should not be significant:

• Stromal infiltrate
• Stromal edema
• Endothelial involvement

What the Conjunctiva Looks Like

The conjunctiva is characteristically:

Quiet or only minimally injected.

This is a useful clue because many infectious and inflammatory keratitides produce much more conspicuous conjunctival inflammation.

What Should Not Be Present

Classic TSPK should not produce:

• Significant mucopurulent discharge
• Stromal suppuration
• Corneal thinning
• Anterior chamber cells
• Hypopyon
• Marked conjunctivitis

If these are present, reconsider the diagnosis.

How the Disease Evolves

Individual lesions may:

• Appear
• Fade
• Disappear
• Recur elsewhere

The disease commonly follows a:

Relapsing-remitting course lasting years.

Patients may have long symptom-free intervals between flares.

How the Diagnosis Is Made

TSPK is primarily a:

Clinical diagnosis

based on:

1. Characteristic epithelial lesions
2. Minimal conjunctival inflammation
3. Bilateral or asymmetric recurrent course
4. Absence of stromal or anterior chamber disease

No routine laboratory testing is necessary.

Is Corneal Scraping Usually Needed?

No.

Corneal cultures or scrapings are unnecessary in typical TSPK.

They should be considered when findings are atypical and infection is suspected, such as:

• Significant pain
• Stromal infiltrate
• Epithelial ulcer
• Contact lens-associated keratitis
• Anterior chamber inflammation

Role of Slit-Lamp Photography

Photography can be useful for:

• Documenting baseline disease
• Comparing recurrent episodes
• Teaching purposes

but is not needed to establish the diagnosis.

Role of Confocal Microscopy

In vivo confocal microscopy may demonstrate epithelial and subepithelial abnormalities, but it is primarily:

A research or adjunctive tool

rather than a routine diagnostic test.

Important Diagnostic Mimics

The differential diagnosis includes:

• Adenoviral keratoconjunctivitis
• Dry eye-related superficial punctate keratitis
• Toxic medicamentosa
• Contact lens-related epithelial disease
• Early infectious keratitis
• Recurrent corneal erosion
• Exposure keratopathy
• Thygeson-like lesions from other causes

Distinguishing It From Adenoviral Keratitis

Adenoviral keratoconjunctivitis typically has:

• Marked conjunctival injection
• Follicular conjunctivitis
• Preauricular lymphadenopathy
• Recent contagious red-eye illness

Later adenoviral disease may leave:

Subepithelial infiltrates

that can resemble TSPK.

TSPK instead usually has:

• Quiet conjunctiva
• Recurrent epithelial lesions
• No preceding acute conjunctivitis

Distinguishing It From Dry Eye Disease

Dry eye usually causes:

• Diffuse punctate epithelial staining
• Interpalpebral distribution
• Tear-film abnormalities
• Conjunctival staining

TSPK produces:

Discrete coarse gray-white epithelial lesions with clear intervening cornea.

Distinguishing It From Infectious Keratitis

Bacterial or fungal keratitis typically shows:

• Focal stromal infiltrate
• Epithelial defect
• Significant pain
• Conjunctival injection
• Possible anterior chamber reaction

These findings should not be attributed to uncomplicated TSPK.

First Approach in Mild Disease

If the patient has:

• Few lesions
• Minimal symptoms
• Good vision

management may consist of:

Observation and lubrication.

Preservative-free artificial tears can reduce:

• Irritation
• Foreign-body sensation

Most Effective Treatment for Symptomatic Flares

The traditional and most rapidly effective treatment is:

A low-potency topical corticosteroid

Examples include:

• Fluorometholone
• Loteprednol

Treatment usually produces rapid improvement in:

• Symptoms
• Corneal lesions

Why Potent Steroids Are Usually Unnecessary

TSPK is generally highly steroid-responsive.

Therefore the goal is to use:

The lowest potency and frequency necessary to control symptoms

rather than prolonged high-dose corticosteroid treatment.

Why the Steroid Taper Must Be Slow

Recurrence commonly occurs when topical corticosteroids are stopped abruptly.

A typical strategy is:

Gradual taper over weeks to months

Some patients eventually require very infrequent maintenance dosing.

Risks of Long-Term Steroid Therapy

Repeated or prolonged corticosteroid use can cause:

• Ocular hypertension
• Steroid-induced glaucoma
• Posterior subcapsular cataract
• Increased susceptibility to infection

Therefore IOP should be monitored during extended treatment.

Steroid-Sparing Treatment

Topical immunomodulators are particularly useful for:

• Frequent recurrences
• Steroid dependence
• Steroid responders
• Long-term disease

Common options include:

Topical cyclosporine

and, in selected cases:

Topical tacrolimus.

Role of Cyclosporine

Topical cyclosporine can:

• Reduce symptoms
• Suppress recurrent lesions
• Reduce dependence on corticosteroids

Its effect is usually:

Slower than topical steroid therapy

so it is more useful for long-term disease control than immediate relief.

Role of Tacrolimus

Topical tacrolimus has also been reported to control recurrent TSPK, particularly when:

• Steroids cannot be used safely
• Cyclosporine is inadequate or poorly tolerated

Use is typically under corneal specialist supervision.

Therapeutic Contact Lenses

A soft bandage contact lens can occasionally reduce symptoms by shielding the corneal epithelium.

However, this is not routine first-line therapy because contact lenses introduce risks such as:

• Microbial keratitis
• Hypoxia
• Lens-related inflammation

They are generally reserved for:

Selected refractory symptomatic cases.

Are Antiviral Drugs Useful?

Older reports investigated agents such as:

• Trifluridine
• Idoxuridine

These are:

Not standard modern therapy for TSPK.

There is no established viral etiology requiring routine antiviral treatment.

Important Modern Correction About Idoxuridine

Idoxuridine is obsolete for this indication and can produce significant:

Corneal epithelial toxicity.

It should not be used to treat TSPK.

Does Steroid Treatment Prolong the Disease?

Older literature suggested that corticosteroids might prolong the total disease course.

This remains uncertain.

The clinically important point is that corticosteroids:

• Relieve symptoms rapidly
• Suppress lesions effectively
• Do not cure the underlying tendency to recur

Therefore treatment should focus on:

Symptom control with minimum long-term steroid exposure.

Refractive Surgery Considerations

TSPK has been reported to recur after:

• LASIK
• PRK

Elective corneal refractive surgery should generally be deferred while disease is:

Active or unstable.

An Important Correction About LASIK vs PRK

Older case reports suggested a lower recurrence risk after PRK than LASIK.

There is:

Insufficient evidence to consider PRK reliably safer than LASIK specifically for TSPK.

The more important principle is to operate only after a prolonged period of:

Stable ocular surface disease.

When Specialist Referral Is Useful

Corneal specialist evaluation is appropriate when:

• Diagnosis is uncertain
• Lesions are atypical
• Disease is unilateral and persistent
• The patient becomes steroid-dependent
• IOP rises with treatment
• Symptoms persist despite appropriate therapy

Monitoring During Treatment

Follow-up should assess:

• Visual acuity
• Number and location of corneal lesions
• Symptoms
• Corneal staining
• IOP when steroids are being used

There is no single follow-up interval appropriate for every patient.

Expected Long-Term Course

TSPK may recur intermittently for:

Several years or even decades

but eventually tends to become less active in many patients.

The disease generally does not produce progressive destructive corneal disease.

Visual Prognosis

Long-term visual prognosis is:

Excellent.

Most patients do not develop:

• Significant corneal scarring
• Stromal opacity
• Permanent visual loss

Visual disturbance during active episodes is usually reversible.

Potential Problems During Management

The disease itself rarely causes serious complications.

Most clinically important complications relate to therapy, particularly:

• Steroid-induced ocular hypertension
• Glaucoma
• Cataract
• Contact lens-related infection

High-Yield Takeaways

• Thygeson’s superficial punctate keratitis is a chronic, recurrent epithelial keratitis characterized by multiple coarse gray-white slightly elevated corneal lesions.
• It is usually bilateral but asymmetric.
• The conjunctiva is characteristically quiet or minimally injected.
• There is usually no stromal inflammation, corneal edema, or anterior chamber reaction.
• Symptoms include foreign-body sensation, irritation, photophobia, and mild fluctuating blur.
• The diagnosis is clinical; laboratory testing, cultures, and imaging are unnecessary in typical cases.
• The most important mimics include adenoviral subepithelial keratitis, dry eye, toxic keratopathy, and infectious keratitis.
• Mild or asymptomatic disease can be managed with observation and preservative-free lubrication.
• Symptomatic flares respond rapidly to low-potency topical corticosteroids, usually followed by a very gradual taper.
• Long-term corticosteroid use requires monitoring for ocular hypertension, glaucoma, and cataract.
• Topical cyclosporine is an important steroid-sparing option for recurrent or steroid-dependent disease; tacrolimus may be useful in selected cases.
• Routine antiviral treatment is not indicated, because a specific viral cause has never been established.
• Idoxuridine is obsolete and potentially toxic to the corneal epithelium.
• Elective corneal refractive surgery should generally be avoided during active disease; there is insufficient evidence that PRK reliably prevents recurrence compared with LASIK.
• TSPK often follows a relapsing-remitting course over many years, but permanent corneal scarring or significant long-term visual loss is uncommon.
• Overall visual prognosis is excellent.